In a MAPSI programme, value does not come from the tool alone. It emerges when usage becomes regular enough to produce reliable data, faster decisions and a shared view of priorities.
Organisations that achieve a genuine return on investment do not deploy MAPSI as just another component. They use it to reduce management blind spots, improve the reliability of valuable information and establish a collective discipline for keeping data up to date.
1. Start with the pain points that genuinely slow down decision-making
Before even discussing features, the most costly friction points must be identified: scattered information, duplicate data entry, limited visibility, delayed reporting or poor coordination between teams. These pain points provide the basis for prioritising genuinely useful MAPSI use cases.
2. Limit target use cases to accelerate adoption
Successful rollouts rarely begin with a comprehensive catalogue. They focus efforts on a few critical use cases: sharing a common view of progress, tracking bottlenecks, assessing delays objectively and simplifying decision-making. This focus increases effective adoption.
3. Measure adoption as an operational performance indicator
Usage rates, data freshness, completion of critical fields and update frequency must be monitored as performance indicators in their own right. Without measurement, a perceived sense of progress often masks value that remains too limited.
4. Make MAPSI part of weekly governance
When MAPSI data is used in management routines, teams make decisions earlier, work from the same factual basis and reduce discussions unsupported by evidence. MAPSI then ceases to be a passive repository and becomes an operational decision-making tool.
At Oling, we have observed that sustainable adoption depends on three drivers: clarity around priority use cases, high standards for data quality and sufficiently regular management governance to turn information into decisions. This combination transforms MAPSI from a technical deployment into a visible performance driver.